Atlas Trials

A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease

Clinical trial NCT04371653 · WITHDRAWN

Trial details

NCT number
NCT04371653
Sponsor
The University of Texas Health Science Center, Houston
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus
Start date
2023-12-01
Primary completion
2024-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.